John Kaldor

Active 1982–2025

242
Papers
30,227
Citations
100
h-index
235
i10-index

Citations

Citations per year for John Kaldor1983: 4 citations1986: 3 citations1987: 6 citations1988: 10 citations1989: 9 citations1990: 21 citations1991: 34 citations1992: 41 citations1993: 51 citations1994: 78 citations1995: 65 citations1996: 104 citations1997: 79 citations1998: 67 citations1999: 87 citations2000: 101 citations2001: 129 citations2002: 129 citations2003: 152 citations2004: 142 citations2005: 171 citations2006: 185 citations2007: 199 citations2008: 185 citations2009: 267 citations2010: 261 citations2011: 209 citations2012: 197 citations2013: 210 citations2014: 166 citations2015: 184 citations2016: 149 citations2017: 137 citations2018: 156 citations2019: 560 citations2020: 530 citations2021: 539 citations2022: 402 citations2023: 265 citations2024: 532 citations2025: 222 citations2026: 4 citations1984–1985: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,617 citing papers, 25% of this breakdownUnited Kingdom: 1,023 citing papers, 9.8% of this breakdownAustralia: 1,019 citing papers, 9.8% of this breakdownFrance: 478 citing papers, 4.6% of this breakdownCanada: 472 citing papers, 4.5% of this breakdownGermany: 329 citing papers, 3.1% of this breakdownItaly: 291 citing papers, 2.8% of this breakdownChina: 283 citing papers, 2.7% of this breakdownNetherlands: 270 citing papers, 2.6% of this breakdownSwitzerland: 243 citing papers, 2.3% of this breakdownSpain: 215 citing papers, 2.1% of this breakdownSweden: 201 citing papers, 1.9% of this breakdown
0%25%Other 28.8%

Fields

  • Medicine66.1%
  • Immunology and Microbiology15.6%
  • Biochemistry, Genetics and Molecular Biology5.3%
  • Health Professions2.7%
  • Social Sciences2.2%
  • Agricultural and Biological Sciences1.2%
  • Other6.9%

Topics

  • HIV/AIDS Research and Interventions4.7%
  • Hepatitis C virus research3.9%
  • HIV Research and Treatment3.7%
  • HIV, Drug Use, Sexual Risk3.7%
  • Reproductive tract infections research3.3%
  • Cervical Cancer and HPV Research3.2%
  • Other77.5%

Coauthors

All papers

Open in search
  1. Carcinogenicity of aspartame, methyleugenol, and isoeugenol

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Charlotte Debras, Aline de Conti, Fatiha El Ghissassi, Emma Fontvieille, Rhea Harewood, John Kaldor, Heidi Mattock, Elisa Pasqual, Gabrielle Rigutto, Hannah Simba, Eero Suonio, Susana Viegas, Roland Wedekind, Mary K. Schubauer‐Berigan, Federica Madia - The Lancet Oncology 2023 cited by 102

  2. Prevalence of scabies and impetigo worldwide: a systematic review

    Authors: , , , - The Lancet Infectious Diseases 2015 cited by 443

  3. Cancer Incidence Before and After Kidney Transplantation

    Authors: , , , , , , , , , - JAMA 2006 cited by 1,120

  4. The public health control of scabies: priorities for research and action

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2019 cited by 212

  5. Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections

    Authors: , , , , , , , , , - Clinical Infectious Diseases 2019 cited by 133

  6. Point-of-care HPV DNA testing of self-collected specimens and same-day thermal ablation for the early detection and treatment of cervical pre-cancer in women in Papua New Guinea: a prospective, single-arm intervention trial (HPV-STAT)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Global Health 2022 cited by 54

  7. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies

    Authors: , , - Journal of Viral Hepatitis 2005 cited by 871

  8. Association between HTLV-1 infection and adverse health outcomes: a systematic review and meta-analysis of epidemiological studies

    Authors: , , , , , - The Lancet Infectious Diseases 2019 cited by 235

  9. Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study

    Authors: , , , , , , , , , , , - The Lancet Infectious Diseases 2014 cited by 305

  10. Very Low Prevalence of Vaccine Human Papillomavirus Types Among 18- to 35-Year Old Australian Women 9 Years Following Implementation of Vaccination

    Authors: , , , , , , , , , , - The Journal of Infectious Diseases 2018 cited by 144

  11. Effectiveness evaluation of digital contact tracing for COVID-19 in New South Wales, Australia

    Authors: , , , , - The Lancet Public Health 2022 cited by 112

  12. Mass Drug Administration for Scabies Control in a Population with Endemic Disease

    Authors: , , , , , , , , , , - New England Journal of Medicine 2015 cited by 279

  13. Risk of Pelvic Inflammatory Disease in Relation to Chlamydia and Gonorrhea Testing, Repeat Testing, and Positivity: A Population-Based Cohort Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2017 cited by 117

  14. The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: Estimates of Radiation-Related Cancer Risks

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hilde Engels, Gerda Engholm, Gabriel Guliš, Rima R. Habib, K Holan, H. Hyvönen, A. Kerekes, Juozas Kurtinaitis, H Malker, Marco Martuzzi, A. Mastauskas, Annabelle Monnet, Mirjana Moser, Mark S. Pearce, David B. Richardson, Fernando Rodríguez‐Artalejo, A. Rogel, Hélène Tardy, M. Telle‐Lamberton, I Turai, M. Usel, Katalin Veress - Radiation Research 2007 cited by 679

  15. Population effectiveness of opportunistic chlamydia testing in primary care in Australia: a cluster-randomised controlled trial

    Authors: , , , , , , , , , , , , - The Lancet 2018 cited by 104

  16. Mass Drug Administration for the Control of Scabies: A Systematic Review and Meta-analysis

    Authors: , , , , , - Clinical Infectious Diseases 2022 cited by 48

  17. Adverse pregnancy and neonatal outcomes associated withNeisseria gonorrhoeae:systematic review and meta-analysis

    Authors: , , , , , , , , , , - Sexually Transmitted Infections 2021 cited by 100

  18. Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection

    Authors: , , , , , , , , , - Clinical Microbiology Reviews 2022 cited by 70

  19. Effect of a School-Based Educational Intervention About the Human Papillomavirus Vaccine on Psychosocial Outcomes Among Adolescents

    Authors: , , , , , , , , , , , , , , , , , , , , - JAMA Network Open 2021 cited by 41

  20. Empirical Bayes Estimates of Age-Standardized Relative Risks for Use in Disease Mapping

    Authors: , - Biometrics 1987 cited by 1,273

  21. Risk of cancer after low doses of ionising radiation: retrospective cohort study in 15 countries

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hilde Engels, Gerda Engholm, Gabriel Guliš, Rima R. Habib, K Holan, H. Hyvönen, A. Kerekes, Juozas Kurtinaitis, H Malker, Marco Martuzzi, A. Mastauskas, Annabelle Monnet, Mirjana Moser, Mark S. Pearce, David B. Richardson, Fernando Rodríguez‐Artalejo, A. Rogel, Hélène Tardy, M. Telle‐Lamberton, I Turai, M. Usel, Katalin Veress - BMJ 2005 cited by 600

  22. A framework for scabies control

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - PLoS neglected tropical diseases 2021 cited by 82

  23. Adverse pregnancy and birth outcomes associated with Mycoplasma hominis, Ureaplasma urealyticum and Ureaplasma parvum : a systematic review and meta-analysis

    Authors: , , , , , , , - BMJ Open 2022 cited by 66

  24. Fall in Human Papillomavirus Prevalence Following a National Vaccination Program

    Authors: , , , , , , , , , - The Journal of Infectious Diseases 2012 cited by 262